Ignite Creation Date:
2024-05-06 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 12:52 PM
Study NCT ID:
NCT03643549
Status:
RECRUITING
Last Update Posted:
2024-02-29
First Post:
2018-08-21
Brief Title:
Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter BORTEM-17
Sponsor:
Haukeland University Hospital
Organization:
Haukeland University Hospital
Organization Data
Organization:
Haukeland University Hospital
Class:
OTHER
Study ID:
20172084
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Haukeland University Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| University of Oslo | OTHER |
| Oslo University Hospital | OTHER |
| St Olavs Hospital | OTHER |
| University Hospital of North Norway | OTHER |
| University of Bergen | OTHER |
| University of Bonn | OTHER |